[1] 庄勤建,邱隆敏,姚新生,等. CD4 + CD25 + 调节性T细胞与乙型肝炎病毒感染的研究进展. 世界华人消化杂志,2012,20(24): 2248-2253. [2] 吴银亚,谭善忠. CD4 + CD25 + 调节性T淋巴细胞在慢性乙型肝炎发病机制中的作用. 中华传染病杂志,2012,30(9):563-565. [3] 孙学华,刘巧丽,李曼,等. 慢性乙型肝炎患者CD4 + 和CD8 + T细胞亚群的研究. 细胞与分子免疫学杂志,2011,27(5):545-547. [4] Fabrizi F,Dixit V,Martin P,et al. Meta-analysis:The impact of nutritional status on the immune response to hepatitis B virus vaccine in chronic kidney disease. Dig Dis Sci,2012,(5):1366-1372. [5] 中华医学会肝病学分会和感染病学分会.慢性乙型肝炎防治指南(2010年版). 实用肝脏病杂志,2011,14(2):81-89. [6] Sakaguchi S,Sakaguchi N,Shimizu J,et al. Immunologic tolerance maintained by CD25 + CD4 + regulatory T cells:their common role in controlling autoimmunity,tumor immunity,and transplantation tolerance. Immunol Rev,2001,182:18-32. [7] Yang PI,Althage A,Chung J,et al. Immune effectors required for hepatitis B virus clearance. Proc Nat1 Acad Sci USA,2010,107(4):798-802. |